UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

The Journal of experimental medicine, 1994-07, Vol.180 (1), p.347-352

1994

Volltextzugriff (PDF)

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

JNCI : Journal of the National Cancer Institute, 1996-01, Vol.88 (2), p.100-108

1996

Volltextzugriff (PDF)

Development of an autologous canine cancer vaccine system for resectable malignant tumors in dogs

Veterinary immunology and immunopathology, 2016-12, Vol.182, p.95-100

2016

Volltextzugriff (PDF)

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2

Journal of clinical oncology, 1994-07, Vol.12 (7), p.1475-1483

1994

Volltextzugriff (PDF)

Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2

JNCI : Journal of the National Cancer Institute, 1994-08, Vol.86 (15), p.1159-1166

1994

Volltextzugriff (PDF)

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

The New England journal of medicine, 1987-04, Vol.316 (15), p.898

1987

Volltextzugriff (PDF)

Identification of a Human Melanoma Antigen Recognized by Tumor-Infiltrating Lymphocytes Associated with in vivo Tumor Rejection

Proceedings of the National Academy of Sciences - PNAS, 1994-07, Vol.91 (14), p.6458-6462

1994

Volltextzugriff (PDF)

Human Mig chemokine: biochemical and functional characterization

The Journal of experimental medicine, 1995-11, Vol.182 (5), p.1301-1314

1995

Volltextzugriff (PDF)

Enhanced Tumor Growth of Both Primary and Established Human and Murine Tumor Cells in Athymic Mice After Coinjection With Matrigel

JNCI : Journal of the National Cancer Institute, 1991-06, Vol.83 (11), p.769-774

1991

Volltextzugriff (PDF)

Clinical and Immune Responses in Advanced Melanoma Patients Immunized With an Anti-Idiotype Antibody Mimicking Disialoganglioside GD2

Journal of clinical oncology, 2000-01, Vol.18 (2), p.376-384

2000

Volltextzugriff (PDF)

T-Cell Receptor Usage by Melanoma-Specific Clonal and Highly Oligoclonal Tumor-Infiltrating Lymphocyte Lines

Proceedings of the National Academy of Sciences - PNAS, 1994-03, Vol.91 (7), p.2829-2833

1994

Volltextzugriff (PDF)

Growth of tumor‐infiltrating lymphocytes from human solid cancers: Summary of a 5‐year experience

International journal of cancer, 1996-02, Vol.65 (4), p.413-421

1996

Volltextzugriff (PDF)

Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer

Leukemia, 1999-10, Vol.13 (10), p.1608-1616

1999

Volltextzugriff (PDF)

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1

The Journal of immunology (1950), 1995-03, Vol.154 (5), p.2257

1995

Volltextzugriff (PDF)

Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma

Journal of immunotherapy, 2000-01, Vol.23 (1), p.17-27

2000

Volltextzugriff (PDF)

Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis

British journal of cancer, 1997, Vol.75 (10), p.1421-1431

1997

Volltextzugriff (PDF)

Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes

The Journal of immunology (1950), 1995-08, Vol.155 (3), p.1343

1995

Volltextzugriff (PDF)

Reorientation and fusion of cytotoxic T lymphocyte granules after interaction with target cells as determined by high resolution cinemicrography

The Journal of immunology (1950), 1986, Vol.136 (2), p.377

1986

Volltextzugriff (PDF)

CD80 expression in an HLA‐A2‐positive human non‐small cell lung cancer cell line enhances tumor‐specific cytotoxicity of HLA‐A2‐positive T cells derived from a normal donor and a patient with non‐small cell lung cancer

International journal of cancer, 1998-12, Vol.78 (6), p.685-694

1998

Volltextzugriff (PDF)

Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes

Cancer Immunology Immunotherapy, 1994-09, Vol.38 (5), p.299-303

1994

Volltextzugriff (PDF)

Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition

The Journal of immunology (1950), 1995-01, Vol.154 (2), p.762

1995

Volltextzugriff (PDF)

The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity

The Journal of immunology (1950), 1987-12, Vol.139 (11), p.3614

1987

Volltextzugriff (PDF)

The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer

Journal of Immunological Methods, 1991-05, Vol.139 (1), p.1-16

Yannelli, John R.

1991

Volltextzugriff (PDF)

Generation and characterization of non-small-cell lung cancer cell lines and clones for use in the study of immunotherapy

Cancer biotherapy & radiopharmaceuticals, 2010-06, Vol.25 (3), p.269

Yannelli, John R

2010

Volltextzugriff (PDF)

Effects of interleukin 4 upon human tumoricidal cells obtained from patients bearing solid tumors

Journal of leukocyte biology, 1991-02, Vol.49 (2), p.139-151

1991

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(67)
Science & Technology
(58)
Life Sciences & Biomedicine
(56)
Biological And Medical Sciences
(40)
Immunotherapy
(33)
Oncology
(29)
Medical Sciences
(28)
Immunology
(27)
Lymphocytes, Tumor-Infiltrating - Immunology
(22)
Neoplasms - Therapy
(20)
Melanoma - Immunology
(19)
Tumor Cells, Cultured
(19)
Female
(18)
Male
(18)
Medicine, Research & Experimental
(16)
Research & Experimental Medicine
(16)
Animals
(15)
Antineoplastic Agents
(15)
Molecular Sequence Data
(15)
Pharmacology. Drug Treatments
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

Development of an autologous canine cancer vaccine system for resectable malignant tumors in dogs

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2

Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

Identification of a Human Melanoma Antigen Recognized by Tumor-Infiltrating Lymphocytes Associated with in vivo Tumor Rejection

Human Mig chemokine: biochemical and functional characterization

Enhanced Tumor Growth of Both Primary and Established Human and Murine Tumor Cells in Athymic Mice After Coinjection With Matrigel

Clinical and Immune Responses in Advanced Melanoma Patients Immunized With an Anti-Idiotype Antibody Mimicking Disialoganglioside GD2

T-Cell Receptor Usage by Melanoma-Specific Clonal and Highly Oligoclonal Tumor-Infiltrating Lymphocyte Lines

Growth of tumor‐infiltrating lymphocytes from human solid cancers: Summary of a 5‐year experience

Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1

Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma

Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis

Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes

Reorientation and fusion of cytotoxic T lymphocyte granules after interaction with target cells as determined by high resolution cinemicrography

CD80 expression in an HLA‐A2‐positive human non‐small cell lung cancer cell line enhances tumor‐specific cytotoxicity of HLA‐A2‐positive T cells derived from a normal donor and a patient with non‐small cell lung cancer

Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes

Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition

The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity

The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer

Generation and characterization of non-small-cell lung cancer cell lines and clones for use in the study of immunotherapy

Effects of interleukin 4 upon human tumoricidal cells obtained from patients bearing solid tumors

Suchergebnisse filtern